Nadine Mikhaeel-Kamel, MD

Oncologist

Clinical Cancer Research

Associated Clinical Trials for Nadine Mikhaeel-Kamel, MD

NCT05812807

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy

This study is not currently enrolling.

Associated Conditions: Breast Cancer

Research Area: Clinical Cancer Research

This study is being done to answer the following question: Among patients with early-stage TNBC who achieve a pCR after preoperative chemotherapy in combination with pembrolizumab, will observation...

More clinical trials loaded

Back to Top